Use of dairy products, lactose, and calcium and risk of ovarian cancer Results from a Danish case-control study

Acta Oncologica

Volumn 51, Issue 4, 2012, Pages 454-464

  Faber, Mette T ^a   Jensen, Allan ^a   Søgaard, Marie ^a   Høgdall, Estrid ^a   Høgdall, Claus ^b   Blaakær, Jan ^c   Kjær, Susanne K ^a,b  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b University of Copenhagen   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LACTOSE; YOGHURT;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CANCER RISK; CHEESE; CONTROLLED STUDY; DAIRY PRODUCT; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MILK; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CALCIUM, DIETARY; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; DAIRY PRODUCTS; DENMARK; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LACTOSE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 84859774784     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.636754     Document Type: Article

References (29)

1. Karim-Kos HE, de VE, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44: 1345-89.
2. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klintå, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 3.6. 2010. Association of the Nordic Cancer Registries. Danish Cancer Society.
3. Cramer DW. Lactase persistence and milk consumption as determinants of ovarian cancer risk. Am J Epidemiol 1989; 130:904-10.
4. Larsson SC, Bergkvist L, Wolk A. Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 2004;80:1353-7.
5. Larsson SC, Orsini N, Wolk A. Milk, milk products and lactose intake and ovarian cancer risk: A meta-analysis of epidemiological studies. Int J Cancer 2006;118:431-41.
6. Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, et al. Dairy products and ovarian cancer: A pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2006;15:364-72.
7. Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 2006;94:165-70.
8. Qin LQ, Xu JY, Wang PY, Hashi A, Hoshi K, Sato A. Milk/ dairy products consumption, galactose metabolism and ovarian cancer: Meta-analysis of epidemiological studies. Eur J Cancer Prev 2005;14:13-9.
9. Goodman MT, Wu AH, Tung KH, McDuffi e K, Kolonel LN, Nomura AM, et al. Association of dairy products, lactose, and calcium with the risk of ovarian cancer. Am J Epidemiol 2002;156:148-57.
10. Koralek DO, Bertone-Johnson ER, Leitzmann MF, Sturgeon SR, Lacey JV, Jr., Schairer C, et al. Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 2006;56:22-30.
11. Webb PM, Bain CJ, Purdie DM, Harvey PW, Green A. Milk consumption, galactose metabolism and ovarian cancer (Australia). Cancer Causes Control 1998;9:637-44.
12. Gallus S, Bravi F, Talamini R, Negri E, Montella M, Ramazzotti V, et al. Milk, dairy products and cancer risk (Italy). Cancer Causes Control 2006;17:429-37.
13. Fairfi eld KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, et al. A prospective study of dietary lactose and ovarian cancer. Int J Cancer 2004;110:271-7.
14. Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, et al. Prospective study of diet and ovarian cancer. Am J Epidemiol 1999;149:21-31.
15. Cramer DW, Greenberg ER, Titus-Ernstoff L, Liberman RF, Welch WR, Li E, et al. A case-control study of galactose consumption and metabolism in relation to ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:95-101.
16. Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, et al. Diet and ovarian cancer risk: A casecontrol study in Italy. Int J Cancer 2001;93:911-5.
17. Cramer DW, Harlow BL, Willett WC, Welch WR, Bell DA, Scully RE, et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2:66-71.
18. Risch HA, Jain M, Marrett LD, Howe GR. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control 1994;5:540-8.
19. Kiani F, Knutsen S, Singh P, Ursin G, Fraser G. Dietary risk factors for ovarian cancer: The Adventist Health Study (United States). Cancer Causes Control 2006;17: 137-46.
20. Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, et al. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 2004;164:2253-9.
21. Gjerstorff ML. The Danish cancer registry. Scand J Public Health 2011;39(Suppl):42-5.
22. Danish Food Composition Databank [Internet]. Version 7.01. [cited 2010 Oct 26]. Available from: http://www. foodcomp.dk/.
23. Danish Dairy Board. Dairy Statistics 2007. 2008.
24. Danish Veterinary and Food Administration. Forsyningen af fø devarer 1955-1999 [Supply of foods 1955 - 1999] (in Danish). 2001.
25. Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981;214:1145-7.
26. Swartz WJ, Mattison DR. Galactose inhibition of ovulation in mice. Fertil Steril 1988;49:522-6.
27. Jiang F, Bao J, Li P, Nicosia SV, Bai W. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 2004;279: 53213-21.
28. McCarty MF. Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses 2000;54:475-82.
29. L angdon SP, Hawkes MM, Lawrie SS, Hawkins RA, Tesdale AL, Crew AJ, et al. Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer 1990; 62:213-6.